# Intravenous Iron Sucrose in Arthroplasty

> **NCT02544828** · PHASE4 · UNKNOWN · sponsor: **Konkuk University Medical Center** · enrollment: 76 (estimated)

## Conditions studied

- Osteoarthritis

## Interventions

- **DRUG:** Iron Sucrose 200mg
- **DRUG:** placebo

## Key facts

- **NCT ID:** NCT02544828
- **Lead sponsor:** Konkuk University Medical Center
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2015-11
- **Primary completion:** 2016-07
- **Final completion:** 2016-09
- **Target enrollment:** 76 (ESTIMATED)
- **Last updated:** 2015-09-09


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02544828

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02544828, "Intravenous Iron Sucrose in Arthroplasty". Retrieved via AI Analytics 2026-06-06 from https://api.ai-analytics.org/clinical/NCT02544828. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*